Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

Rummel, Mathias; Al-Batran, S.; Kim, Soo-Z.; Welslau, Manfred; Hecker, Ralf; Kofahl-Krause, Dorothea; Josten, Klaus-M.; Dürk, Heinz; Rost, A.; Neise, Michael; von Grünhagen, Ulrich; Uwe Chow, Kai; L. Hansmann, M.; Hoelzer, Dieter; S. Mitrou, Paris

doi:10.1200/jco.2005.08.100

Public

Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

Published in Journal of Clinical Oncology • May 20, 2005

Authors:

Mathias Rummel

S. Al-Batran

Soo-Z. Kim

Abstract

PURPOSE: The aim of this multicenter-study was to evaluate the progression-free survival, response rate and toxicity of the combination of bendamustine and rituximab (BR) in patients with mantle cell or low-grade lymphomas in first to third relapse or refractory to previous treatment. PATIENTS AND M...

Subject

Medicine

Leukocytopenia

Mantle cell lymphoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!